Physician profile
Jay Howington
NPI 1326037367
$161,806.92
in general payments reported to CMS, 2019-2025
41 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $640 · 2021: $11K · 2022: $23K · 2023: $13K · 2024: $46K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $71K · Travel and Lodging: $23K · Food and Beverage: $5,652 · Gift: $7.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,310.54 |
| Travel and Lodging | $23,459.11 |
| Food and Beverage | $5,651.94 |
| Gift | $7.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $151,639.62 | 2019-2025 | Emboguard, Trufill, Cerepak Uniform |
| Depuy Synthes Sales INC. | $3,351.17 | 2019-2025 | Cerenovus Enterprise, Embotrap, Trufill |
| Boston Scientific Corporation | $2,017.87 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Ge Healthcare | $1,506.61 | 2019-2021 | |
| Gt Medical Technologies, INC | $401.51 | 2021 | |
| Rapid Medical Ltd | $279.34 | 2023 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Integra Lifesciences Corporation | $255.36 | 2021-2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Medtronic, INC. | $251.22 | 2021-2025 | Pipeline, Midas Rex, Kyphon Express II Kyphopak Tray |
| Arbor Pharmaceuticals, INC. | $227.23 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $178.00 | 2019-2024 | Htr-Pekk |
| Stryker Corporation | $152.90 | 2021-2024 | Target, Trevo, Spinejack |
| Penumbra, INC. | $135.32 | 2019 | |
| Globus Medical, INC. | $129.11 | 2025 | Senza |
| Viz.Ai, INC. | $123.67 | 2022 | |
| Balt USA, LLC | $110.18 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synaptive Medical INC. | $94.81 | 2019 | |
| Carl Zeiss Meditec, INC. | $83.72 | 2019 | |
| Nevro Corp. | $81.00 | 2019-2024 | Senza |
| Microtransponder, INC. | $72.20 | 2025 | |
| Acera Surgical, INC. | $70.71 | 2023-2024 | Restrata Wound Matrix |
| Abbott Laboratories | $65.27 | 2020-2025 | Xact, Acculink |
| Lemaitre Vascular, INC. | $56.48 | 2022 | |
| Medtronic USA, INC. | $49.48 | 2019-2020 | |
| Cardiva Medical, INC. | $46.93 | 2019-2024 | Cardiva Vascade 6/7f Vcs |
| Irras USA, INC. | $45.43 | 2021 | |
| Philips North America LLC | $44.50 | 2021 | |
| Monteris Medical Corporation | $44.50 | 2024 | Neuroblate |
| Inspiremd Ltd | $42.33 | 2025 | Cguard Prime Carotid Stent System |
| Portola Pharmaceuticals, LLC | $37.68 | 2019 | |
| Nanohive Medical LLC | $37.27 | 2025 | Csa, Alif Sa |
| Radius Health, INC. | $21.33 | 2021 | |
| Cardinal Health 414 LLC | $20.95 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $20.56 | 2022 | |
| Pfizer INC. | $18.61 | 2024 | |
| Azurity Pharmaceuticals, INC. | $17.00 | 2023 | Gliadel |
| Misonix INC | $15.42 | 2019 | |
| Ossdsign USA Incorporated | $13.53 | 2025 | Ossdsign Catalyst |
| Kyocera Medical Technologies, INC. | $12.86 | 2025 | |
| Orthofix Medical, INC. | $12.44 | 2020 | |
| Microvention, INC. | $11.67 | 2021 | |
| Novocure INC. | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Howington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.